Mega Genomics Limited

Research Mega Genomics Limited (6667.HK) on Bullrun: market cap HKD 1.59B, P/E 51.4, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker6667.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryDiagnostics & Research
CurrencyHKD
Market capHKD 1.59B
P/E51.4
Dividend yield2.4%
Financial periodFY2025
RevenueCNY 247.15M
Revenue growth50.5%
Net incomeCNY 27.02M
Free cash flow-CNY 16.68M
Gross margin47.5%

Valuation Snapshot

latest market cap is HKD 1.59B; P/E is 51.4; dividend yield is 2.4%.

Peer valuation comparison

Latest P/E is 51.36x versus a Healthcare sector median of 21.69x (136.8% above).

Latest dividend yield is 2.39% versus a Healthcare sector median of 2.41%.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 247.15M	CNY 27.02M	-CNY 16.68M	47.5%	n/a	CNY 415.59M	CNY 29.37M	CNY 610.94M
FY2024	CNY 164.23M	CNY 45.05M	CNY 56.38M	72.7%	0.22	CNY 490.26M	CNY 34.40M	CNY 614.68M
FY2023	CNY 151.30M	CNY 30.04M	CNY 127.59M	58.4%	0.14	CNY 518.29M	CNY 48.56M	CNY 644.83M
FY2022	CNY 145.73M	-CNY 17.62M	-CNY 12.10M	56.1%	-0.09	CNY 399.83M	CNY 10.99M	CNY 618.00M
FY2021	n/a	n/a	n/a	n/a	0.62	n/a	n/a	n/a

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 1.59B	51.4	2.4%	0.17

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.17 HKD, yield 2.4%.

About Mega Genomics Limited

Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China. It offers brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer's disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson's disease risk assessment; full-scale cancer risk assessment packages; myocardial infarction and heart failure genetic testing;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

WuXi XDC Cayman Inc. (2268.HK) Yunkang Group Limited (2325.HK) WuXi AppTec Co., Ltd. (2359.HK) BGI Genomics Co., Ltd (300676.SZ) Hangzhou Tigermed Consulting Co., Ltd (3347.HK) WuXi AppTec Co., Ltd. (603259.SS) Joinn Laboratories(China)Co.,Ltd. (6127.HK) Biosino Bio-Technology and Science Incorporation (8247.HK) Adicon Holdings Limited (9860.HK) Kindstar Globalgene Technology, Inc. (9960.HK) Burning Rock Biotech Ltd (BNR) Shandong Dong-Ee Jiao Co Ltd (000423.SZ)

Frequently asked questions

What is Mega Genomics Limited's market cap?

Mega Genomics Limited's market capitalization is HKD 1.59B.

What is Mega Genomics Limited's P/E ratio?

Mega Genomics Limited's price-to-earnings (P/E) ratio is 51.4.

Does Mega Genomics Limited pay a dividend?

Mega Genomics Limited has a dividend yield of 2.4%.

What does Mega Genomics Limited do?

Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China.